Table 3.
Multivariable Analysis of Select COVID-19-Directed Interventions
| Intervention, β (95%CI) |
|||
|---|---|---|---|
| Remdesivir | Corticosteroids | Clinical Trial Enrollment | |
| Black race | 0.24 (0.18-0.32) | 0.45 (0.35-0.58) | 0.47 (0.32-0.68) |
| Age, per 1 year | 1.02 (1.01-1.03) | 1.00 (0.99-1.01) | 1.00 (0.99-1.02) |
| Female sex | 0.88 (0.70-1.11) | 0.89 (0.71-1.12) | 0.72 (0.54-0.97) |
| BMI, per 1 kg/m2 | 1.01 (0.995-1.03) | 1.00 (0.99-1.02) | 1.02 (1.00-1.04) |
| Diabetes mellitus | 0.91 (0.70-1.18) | 0.94 (0.73-1.21) | 0.88 (0.64-1.21) |
| Hypertension | 0.93 (0.71-1.23) | 1.03 (0.81-1.39) | 0.97 (0.69-1.35) |
| Coronary artery disease | 1.05 (0.75-1.47) | 0.98 (0.70-1.36) | 0.94 (0.61-1.45) |
| Heart failure | 0.81 (0.56-1.19) | 0.91 (0.63-1.31) | 0.43 (0.24-0.77) |
| eGFR at admission, per 1 mL/min | 1.00 (1.00-1.01) | 1.00 (0.99-1.00) | 1.00 (1.00-1.01) |
BMI = body mass index; CI = confidence interval; COVID-19 = coronavirus disease 2019; eGFR = estimated glomerular filtration rate.